Lexicon Pharma (LXRX) Reports In-Line Q1 Loss of 4c/Share
Tweet
Share
E-mailGet Alerts LXRX Hot Sheet
Price: $2.33 +0.87%
Financial Fact:
Subscription and license fees: 31K
Today's EPS Names:
NPK, BOW, LRHC, More
Financial Fact:
Subscription and license fees: 31K
Today's EPS Names:
NPK, BOW, LRHC, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q1 EPS of ($0.04), in-line with the analyst estimate of ($0.04). Revenue for the quarter came in at $1.8 million versus the consensus estimate of $1.1 million.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Otter Tail Corp (OTTR) Tops Q2 EPS by 15c; offers guidance
- Wix.com (WIX) Tops Q2 EPS by 43c
- Atlas Energy Solutions Inc. (AESI) Misses Q2 EPS by 117c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
